PL2173868T3 - Rekombinowane preparaty wybranych frakcji bromelainy - Google Patents
Rekombinowane preparaty wybranych frakcji bromelainyInfo
- Publication number
- PL2173868T3 PL2173868T3 PL08785459T PL08785459T PL2173868T3 PL 2173868 T3 PL2173868 T3 PL 2173868T3 PL 08785459 T PL08785459 T PL 08785459T PL 08785459 T PL08785459 T PL 08785459T PL 2173868 T3 PL2173868 T3 PL 2173868T3
- Authority
- PL
- Poland
- Prior art keywords
- recombinant preparation
- bromelain
- fractions
- bromelain fractions
- recombinant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07018125A EP2036978A1 (en) | 2007-09-14 | 2007-09-14 | Recombinant preparation of selected bromelain fractions |
PCT/EP2008/006564 WO2009033536A1 (en) | 2007-09-14 | 2008-08-08 | Recombinant preparation of selected bromelain fractions |
EP08785459A EP2173868B1 (en) | 2007-09-14 | 2008-08-08 | Recombinant preparation of selected bromelain fractions |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2173868T3 true PL2173868T3 (pl) | 2013-03-29 |
Family
ID=39144517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08785459T PL2173868T3 (pl) | 2007-09-14 | 2008-08-08 | Rekombinowane preparaty wybranych frakcji bromelainy |
Country Status (11)
Country | Link |
---|---|
US (1) | US8409840B2 (pl) |
EP (2) | EP2036978A1 (pl) |
JP (1) | JP2010538622A (pl) |
CN (1) | CN101889083A (pl) |
CA (1) | CA2699429A1 (pl) |
DK (1) | DK2173868T3 (pl) |
ES (1) | ES2395591T3 (pl) |
MX (1) | MX2010002769A (pl) |
PL (1) | PL2173868T3 (pl) |
PT (1) | PT2173868E (pl) |
WO (1) | WO2009033536A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL165334A0 (en) | 2004-11-22 | 2006-01-15 | Mediwound Ltd | Debriding composition from bromelain and methods of producing same |
MY190244A (en) * | 2009-12-17 | 2022-04-08 | International Islamic Univ Malaysia | Method for producing recombinant stem bromelain |
AU2013240271A1 (en) | 2012-03-26 | 2014-10-02 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
CA2868522A1 (en) | 2012-03-26 | 2013-10-03 | Pronutria, Inc. | Charged nutritive proteins and methods |
EP2831100A4 (en) | 2012-03-26 | 2016-02-10 | Pronutria Inc | NUTRIENT PROTEINS AND METHODS |
EP2831099B1 (en) | 2012-03-26 | 2020-04-22 | Axcella Health Inc. | Nutritive fragments, proteins and methods |
AU2014324900A1 (en) | 2013-09-25 | 2016-05-19 | Axcella Health Inc. | Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment |
KR102376345B1 (ko) | 2016-01-31 | 2022-03-18 | 메디운드 리미티드 | 상처 치료용 괴사조직제거 조성물 |
JP6859158B2 (ja) * | 2017-03-31 | 2021-04-14 | 第一工業製薬株式会社 | ポリウレタン樹脂用ポリオール組成物、ポリウレタン樹脂形成性組成物、複合材料 |
CN110477100B (zh) * | 2019-08-22 | 2023-11-07 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种两吃型酸奶固体饮料及其制备方法 |
WO2021255625A1 (en) * | 2020-06-16 | 2021-12-23 | Anatara Lifesciences Limited | Protease composition |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3658651A (en) * | 1970-04-28 | 1972-04-25 | Castle & Cooke | Ion exchange treatment of bromelain |
US4286064A (en) * | 1979-11-05 | 1981-08-25 | Riker Laboratories, Inc. | Process for isolating active debriding agent from bromelain |
GB9313188D0 (en) * | 1993-06-25 | 1993-08-11 | Cortecs Ltd | Medical use of enzymes |
KR100201008B1 (ko) * | 1996-10-09 | 1999-06-15 | 박종헌 | 글루텐 펩타이드를 외인성 고지혈증 및 고콜레스트레롤증 억제에 이용하는 방법 |
CN1091152C (zh) | 1996-12-23 | 2002-09-18 | 茂名市茂辉公司化州分公司 | 菠萝蛋白酶的物理提取方法 |
WO1998038320A1 (en) * | 1997-02-25 | 1998-09-03 | Cortecs (Uk) Limited | Component of bromelain |
US6803038B1 (en) * | 1998-07-15 | 2004-10-12 | Ursapharm Arzneimittel Gmbh | Use of bromelaine proteases for inhibiting blood coagulation |
GB9819138D0 (en) * | 1998-09-02 | 1998-10-28 | Cortecs Uk Ltd | Nucleic acids and proteins from pineapple stem |
JP2002003362A (ja) * | 2000-06-22 | 2002-01-09 | Kyoei Kagaku Kogyo Kk | 皮膚外用剤 |
JP4969741B2 (ja) * | 2001-07-26 | 2012-07-04 | 株式会社ノエビア | 皮膚外用剤 |
JP4411192B2 (ja) * | 2003-12-05 | 2010-02-10 | エフ.ホフマン−ラ ロシュ アーゲー | 組換えで発現されるカルボキシペプチダーゼbおよびその精製 |
AU2004318207B2 (en) * | 2004-03-08 | 2009-12-17 | Syngenta Participations Ag | Self-processing plants and plant parts |
WO2008021543A2 (en) * | 2006-08-17 | 2008-02-21 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
-
2007
- 2007-09-14 EP EP07018125A patent/EP2036978A1/en not_active Withdrawn
-
2008
- 2008-08-08 PT PT87854592T patent/PT2173868E/pt unknown
- 2008-08-08 EP EP08785459A patent/EP2173868B1/en not_active Not-in-force
- 2008-08-08 DK DK08785459.2T patent/DK2173868T3/da active
- 2008-08-08 MX MX2010002769A patent/MX2010002769A/es not_active Application Discontinuation
- 2008-08-08 ES ES08785459T patent/ES2395591T3/es active Active
- 2008-08-08 JP JP2010524367A patent/JP2010538622A/ja active Pending
- 2008-08-08 CN CN2008801067355A patent/CN101889083A/zh active Pending
- 2008-08-08 WO PCT/EP2008/006564 patent/WO2009033536A1/en active Application Filing
- 2008-08-08 US US12/678,280 patent/US8409840B2/en not_active Expired - Fee Related
- 2008-08-08 PL PL08785459T patent/PL2173868T3/pl unknown
- 2008-08-08 CA CA2699429A patent/CA2699429A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT2173868E (pt) | 2013-01-08 |
EP2173868A1 (en) | 2010-04-14 |
US20100272659A1 (en) | 2010-10-28 |
EP2173868B1 (en) | 2012-10-17 |
WO2009033536A1 (en) | 2009-03-19 |
EP2036978A1 (en) | 2009-03-18 |
ES2395591T3 (es) | 2013-02-13 |
JP2010538622A (ja) | 2010-12-16 |
CA2699429A1 (en) | 2009-03-19 |
DK2173868T3 (da) | 2013-02-18 |
CN101889083A (zh) | 2010-11-17 |
MX2010002769A (es) | 2010-09-07 |
US8409840B2 (en) | 2013-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2173868T3 (pl) | Rekombinowane preparaty wybranych frakcji bromelainy | |
IL245994A0 (en) | Extended substituted polypeptides and preparations comprising them | |
IL196004A0 (en) | Refolding of recombinant proteins | |
EP2348049A4 (en) | NEW APPLICATION OF AIMP1 POLYPEPTIDE | |
ZA201109364B (en) | Stabilized protein compositions | |
IL209983A (en) | Compounds of proteins and polypeptides with cross-linking | |
IL194120A0 (en) | Stabilized polypeptide compositions | |
GB0700523D0 (en) | The Stabilisation Of Proteins | |
IL199547A (en) | Preparation of romidapsine | |
ZA200810456B (en) | Lyophilized formulations of anti-EGFR antibodies | |
EP2152304A4 (en) | THERAPEUTIC COMPOSITIONS IN NANOEMULSION FORM AND METHOD OF APPLICATION THEREFOR | |
HK1144823A1 (en) | Compositions and methods of using proislet peptides and analogs thereof | |
IL220386B (en) | Preparations for the elimination of cancer tumors and their uses | |
GB0626021D0 (en) | The stabilisation of proteins | |
IL219470A0 (en) | Compositions containing fractalknie-binding proteins and uses thereof | |
ZA200807964B (en) | Stabilized polypeptide compositions | |
IL198659A (en) | Targeted signals and recombinant proteins containing them | |
EP2270141A4 (en) | Lacritin PART PEPTIDE | |
IL216199A (en) | A peptide containing the sequence ednimvtfrnqasr | |
GB0724953D0 (en) | Methods of peptide modification | |
EP2172550A4 (en) | C-TERMINAL-A-AMIDATED RECOMBINANT ENZYME DERIVATIVE | |
GB0601251D0 (en) | Protein solubilisation composition | |
GB0709037D0 (en) | Isolation of proteins | |
PL380652A1 (pl) | Rozcieracz minicząstek | |
GB0915735D0 (en) | Recombinant protein separation |